Sun Pharma hit by FDA ban on Gujarat plant, shares fall

Sun Pharma hit by FDA ban on Gujarat plant, shares fall

MUMBAI (Reuters) – The U.S. Food and Drug Administration (FDA) has imposed a ban on imports from generic drugmaker Sun Pharmaceutical Industries's(SUN.NS) plant at Karkhadi in Gujarat, in the latest quality blow for India's drug sector. Shares in Sun 

9
Like
Save

Comments

Write a comment

*